Taken together, these findings suggest that LIFR antagonism in GC cell lines reverses the positive modulation of FGFR4, acquisition of an iper-proliferiferative, migratory phenotype and chemoresistance induced by LIF. This evidence concerns the gene LIF and gastric cancer.